Key deals this week: Flex, Nvidia, AbbVie and more
Flex announced on Thursday that it will purchase digital power‑infrastructure specialist EPC Power for $4.4 billion. The acquisition is intended to give Flex new power‑conversion technology for artificial‑intelligence data centers and for grid‑level applications. Flex expects the transaction to close in the fourth quarter of calendar 2026, at which point the California‑based EPC Power will be folded into Flex’s Cloud and Power Infrastructure (CPI) segment.
Power‑conversion Expansion
The deal adds a dedicated hardware capability to Flex’s existing electronics manufacturing services, positioning the company to serve the growing demand for high‑density AI workloads that require efficient power handling. By integrating EPC Power’s expertise, Flex aims to broaden its offering to both cloud operators and utility customers.
Nvidia confirmed on Thursday that it has reached an agreement to acquire AI‑model hub Hugging Face for $12.9 billion, validating earlier media reports. In a statement, CEO Jensen Huang said, “Hugging Face will remain an open platform for the entire AI ecosystem.” He added that Nvidia’s own compute resources will not be mandatory for building on or deploying through the Hugging Face platform, underscoring the intent to keep the service independent.
AI Platform Deal
Nvidia’s move signals a strategic push to embed a widely used open‑source model repository within its broader AI portfolio while preserving the community‑driven nature of the platform. The $12.9 billion price tag reflects the high value placed on data‑centric AI tools that accelerate development across the industry.
Pharmaceutical company AbbVie reported the completion of its $10.9 billion purchase of Apogee Therapeutics on Thursday. The transaction, first reported by The Financial Times in June, represents AbbVie’s largest bolt‑on acquisition since 2019. By adding Apogee’s pipeline, AbbVie seeks to strengthen its position in the biotech segment of its business.
Largest Pharma Bolt‑on
The acquisition expands AbbVie’s portfolio of innovative therapies and aligns with its strategy of bolstering growth through targeted purchases. The $10.9 billion deal underscores the continued appetite among large drug makers for specialty assets that can enhance long‑term revenue streams.
Diversified Energy disclosed on Wednesday that it has agreed to buy privately held Birch Permian Holdings from Elliott Investment Management for roughly $1.8 billion. The transaction is described by Diversified as a step toward becoming a leading operator of assets in the Permian Basin.
Permian Expansion
By adding Birch Permian’s holdings, Diversified Energy expects to increase its production footprint and improve its standing in one of the United States’ most prolific oil‑rich regions. The $1.8 billion purchase reflects the ongoing consolidation trend among energy firms seeking scale in the Permian play.
Collectively, these four transactions illustrate a week of sizable strategic moves across technology, pharmaceuticals and energy. Each company is leveraging sizable capital outlays to secure capabilities that they believe will drive future growth and competitive advantage in their respective markets.
Source: SeekingAlpha · 2026-09-05